Piperacillin/Tazobactam and Probenecid Interaction

Understanding the Piperacillin/Tazobactam and Probenecid Interaction

FDA-approved prescribing information for these two drugs flags their combination as a moderate-severity interaction. Piperacillin/Tazobactam belongs to the Penicillin / Beta-Lactamase Inhibitor class and Probenecid belongs to the Uricosuric Agent class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Probenecid prevents your kidneys from clearing the antibiotic out of your system, which makes the drug stay in your body for a longer time. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Piperacillin/Tazobactam has 7 total documented interactions on file in this dataset, and Probenecid has 37. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: You should not take these together unless your doctor determines the benefits are greater than the risks. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Piperacillin/Tazobactam or Probenecid based on a web page, speak with your prescriber or pharmacist before making any change.